An RNA polymerase II elongation factor encoded by the human ELL gene
about
Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase IIAF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damageESCRT-II's involvement in HIV-1 genomic RNA trafficking and assemblyDegradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTIIThe little elongation complex regulates small nuclear RNA transcriptionFB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activityHuman mediator subunit MED26 functions as a docking site for transcription elongation factorsThe little elongation complex functions at initiation and elongation phases of snRNA gene transcriptionThe interaction between EAP30 and ELL is modulated by MCM2ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELLThe elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesisLeukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteinsEEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemiaThe HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factorRetrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in miceMolecular basis of p53 functional inactivation by the leukemic protein MLL-ELLELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemiaStructure of a conserved domain common to the transcription factors TFIIS, elongin A, and CRSP70The super elongation complex (SEC) and MLL in development and disease.hLARP7 C-terminal domain contains an xRRM that binds the 3' hairpin of 7SK RNAMolecular evidence for a positive role of Spt4 in transcription elongation.COMPASS: a complex of proteins associated with a trithorax-related SET domain protein.In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIISElongin from Saccharomyces cerevisiae.Cloning and characterization of ELL-associated proteins EAP45 and EAP20. a role for yeast EAP-like proteins in regulation of gene expression by glucose.A new hyperrecombination mutation identifies a novel yeast gene, THP1, connecting transcription elongation with mitotic recombination.Identification of the region in yeast S-II that defines species specificity in its interaction with RNA polymerase II.Characterization of a six-subunit holo-elongator complex required for the regulated expression of a group of genes in Saccharomyces cerevisiae.Emerging concepts of epigenetic dysregulation in hematological malignanciesELL2, a new member of an ELL family of RNA polymerase II elongation factorsPhysical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53Identification and biochemical characterization of a novel transcription elongation factor, Elongin A3Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complexNon-templated addition of nucleotides to the 3' end of nascent RNA during RNA editing in PhysarumMisguided transcriptional elongation causes mixed lineage leukemiaThe inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complexU19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia
P2860
Q21562626-AAE40C1D-9A80-41CA-882C-1CF9B36F40AAQ22010427-803F7330-2E20-4AFB-9D39-19DAE2278E4CQ22010909-AC924EB8-2CA2-410C-9FDF-3586046635C1Q22254564-A39838BF-DEC4-4F34-855B-791F686E30B0Q24289566-04E69997-0B60-4855-8275-97165E81F757Q24298733-4F0CDE03-D371-454D-B0AE-E13BDB444D46Q24299540-C7D59945-CA50-4C14-9DFD-A28ACEBA07AAQ24300557-8C7A67CB-F9B1-453F-AD96-64D40E1B5DE7Q24301280-423A8077-C8F5-4BB0-9C78-4CCDD12BAA04Q24310867-8ECDD3F8-00C5-4019-B528-828DFE8FF4E9Q24316411-474E479C-EA97-4EA7-ADAF-AD5C510B194AQ24324047-B8B87C96-6368-465C-A435-649C988CCCBDQ24531614-DB6C01DD-A4FB-4DE0-92BC-269C46E3C4F3Q24550876-056F1F48-DD1A-4094-8544-B7C84A5F7D50Q24554418-4EF5BE93-B918-4E24-AF7A-4C90E36FAD27Q24564948-9303898E-4FA0-4CA0-B6DD-27F99E2D945AQ24596637-9D118CE1-443E-40DD-9C34-D1248606408EQ24647139-D85AC1E4-C850-4241-9647-3C48890710E0Q24675588-370A96F3-EE13-4487-914F-E1FBAD76AFE8Q24683043-0285FFB1-BE0C-4DD6-82B6-B2D10B756339Q27622544-D18F1BE0-C9A9-4837-AC8F-7193DE8E3EB2Q27692038-3C7F8897-610B-4880-8742-F01DF94ABB5FQ27728130-8DB2FCAB-0129-4CDC-9BA2-DEE04E8D9DC2Q27930449-F7101B5C-C7BE-4D21-8D8E-EFCF4F061710Q27931344-159605F1-1BD8-4F65-A6F1-5E50B83D09D9Q27931841-FD148670-E2BF-45A7-96AA-D76CD0CB5C28Q27934153-BBBB916C-69DD-4F59-8C46-7747B4FAB79DQ27935316-B58EAB59-0241-43AC-9319-3C213BC5F499Q27937094-2727ED7B-4F91-4678-BC57-A20A698CC8D3Q27938041-FD959C52-C206-4E4D-A3FA-9211E9ECDF49Q27938073-8822FE0F-CA7B-47CA-81DA-7C3AD290D921Q28074522-A9DE21D6-C7EC-410D-BB83-A324BD7594C9Q28117345-B1453CD8-817B-402A-877D-424EEC5F5EAFQ28198423-D3294B97-E0A8-44FE-B543-ACFF2F12703AQ28216741-2604A3F4-DFF3-4412-BEC4-1F137334BB37Q28247009-713AE3BD-EE8A-4A10-AFD4-16E826ED8FD9Q28360236-CAE21002-117F-4CF2-BD07-864775DD8899Q28471927-F3C7C8D5-4AA3-4D93-87EA-A26D550F0F40Q28582367-47037C4E-9A2B-455E-A115-13AEE8B966CAQ28590029-06EB262B-2B90-4B2F-9D51-5AE0B24DCB46
P2860
An RNA polymerase II elongation factor encoded by the human ELL gene
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
An RNA polymerase II elongation factor encoded by the human ELL gene
@ast
An RNA polymerase II elongation factor encoded by the human ELL gene
@en
An RNA polymerase II elongation factor encoded by the human ELL gene
@en-gb
An RNA polymerase II elongation factor encoded by the human ELL gene
@nl
type
label
An RNA polymerase II elongation factor encoded by the human ELL gene
@ast
An RNA polymerase II elongation factor encoded by the human ELL gene
@en
An RNA polymerase II elongation factor encoded by the human ELL gene
@en-gb
An RNA polymerase II elongation factor encoded by the human ELL gene
@nl
prefLabel
An RNA polymerase II elongation factor encoded by the human ELL gene
@ast
An RNA polymerase II elongation factor encoded by the human ELL gene
@en
An RNA polymerase II elongation factor encoded by the human ELL gene
@en-gb
An RNA polymerase II elongation factor encoded by the human ELL gene
@nl
P2093
P3181
P1433
P1476
An RNA polymerase II elongation factor encoded by the human ELL gene
@en
P2093
A Shilatifard
J W Conaway
K W Jackson
R C Conaway
P304
P3181
P356
10.1126/SCIENCE.271.5257.1873
P407
P577
1996-03-29T00:00:00Z